Abstract | BACKGROUND: METHODS: INA expression was evaluated by immunohistochemistry in a series of 122 gliomas, and correlated to the 1p19q codeletion, a favorable prognostic marker of oligodendroglial tumors. RESULTS: INA expression was strong (>10% positive cells) in 22 cases (22 oligodendroglial tumors and 0 astrocytic tumors), weak (<10% cells) in 14 cases (12 oligodendroglial tumors, 2 glioblastoma with an oligodendroglial component, and 0 astrocytic tumors), and negative in 86 cases (49 oligodendroglial tumors, 9 glioblastoma with an oligodendroglial component, and 28 astrocytic tumors). Among the 27 tumors exhibiting the 1p19q codeletion (all with an oligodendroglial phenotype), INA was detected in 96% (26/27, 18 strong, 8 weak) as compared to 11% (10/95, 4 strong, 6 weak) in the tumors without 1p19q codeletion (with an oligodendroglial or an astrocytic phenotype) (p < 0.001). In oligodendroglial tumors, INA expression specificity for 1p19q codeletion was 86%, sensitivity 96%, positive predictive value 76%, and negative predictive value was 98%. The prognostic impact of INA expression could be evaluated in grade III oligodendroglial tumors. Similar to 1p19q deletion, positive INA expression was correlated with better progression-free survival (52.6 vs 8.7 months [p = 0.001]) and overall survival (121.1 vs 31.4 months [p = 0.0001]). CONCLUSION:
|
Authors | F Ducray, E Crinière, A Idbaih, K Mokhtari, Y Marie, S Paris, S Navarro, F Laigle-Donadey, C Dehais, J Thillet, K Hoang-Xuan, J-Y Delattre, M Sanson |
Journal | Neurology
(Neurology)
Vol. 72
Issue 2
Pg. 156-61
(Jan 13 2009)
ISSN: 1526-632X [Electronic] United States |
PMID | 19139367
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Intermediate Filament Proteins
- alpha-internexin
|
Topics |
- Brain Neoplasms
(diagnosis, genetics)
- Chromosomes, Human, Pair 1
(genetics)
- Chromosomes, Human, Pair 19
(genetics)
- DNA Mutational Analysis
- Disease Progression
- Gene Deletion
- Genes
- Genetic Predisposition to Disease
(genetics)
- Genetic Testing
- Genotype
- Glioma
(diagnosis, genetics)
- Humans
- Intermediate Filament Proteins
(genetics)
- Mutation
(genetics)
- Oligodendroglioma
(diagnosis, genetics)
- Predictive Value of Tests
- Prognosis
|